10-QFiling Date: Aug 3, 2026

AbbVie

abbv-20260630

View SEC Filing

ACC: 0001551152-26-000026

Key Financial MetricsFY2026 · 2026-06-30

Revenue$16.99B

Net Income$3.61B

Total Assets$135.12B

Stockholders' Equity-$5.93B

Operating Cash Flow$7.26B